BS-194

N/A

Report date: 2023/03/25 23:47:44
NME

Base Information

Drug NameBS-194
Drug Alias NameBS-194
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitorsCyclin-dependent kinase 5 inhibitorsCyclin-dependent kinase 1 inhibitors +[5] 
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 1Cyclin-dependent kinase 7 +[5] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesImperial College London
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A